Az inzulinkezelés korai megkezdése 2-es típusú cukorbetegségben

haszon és kockázat

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The introduction of insulin in type 2 diabetes is often too late, though the immediate as well as late consequences of inadequate metabolic control are well known. That is the reason, why a special attention is given in recent therapeutic guidelines for the importance of early, at least timely insulinisation. This review article summarizes the advantages (mitigation of the beta-cell dysfunction, long lasting good metabolic control) and potential risks (hypoglycemia, weight gain, possible deteriorating patient complience) of early or timely insulin therapy. It is pointed out that the introduction of insulin is effective and safe therapeutic option during the whole course of type 2 diabetes, the use of different regimes is suitable to reach and maintain the individual glycemic target and, with a structured patient education, it does not disturb the quality of life and the compliance of patients. Orv. Hetil., 2014, 155(7), 255-261.

Original languageHungarian
Pages (from-to)255-261
Number of pages7
JournalOrvosi Hetilap
Volume155
Issue number7
DOIs
Publication statusPublished - Feb 1 2014

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Az inzulinkezelés korai megkezdése 2-es típusú cukorbetegségben : haszon és kockázat. / Winkler, G.

In: Orvosi Hetilap, Vol. 155, No. 7, 01.02.2014, p. 255-261.

Research output: Contribution to journalArticle

@article{aa93b0f8de194996ac2b7125a42ff992,
title = "Az inzulinkezel{\'e}s korai megkezd{\'e}se 2-es t{\'i}pus{\'u} cukorbetegs{\'e}gben: haszon {\'e}s kock{\'a}zat",
abstract = "The introduction of insulin in type 2 diabetes is often too late, though the immediate as well as late consequences of inadequate metabolic control are well known. That is the reason, why a special attention is given in recent therapeutic guidelines for the importance of early, at least timely insulinisation. This review article summarizes the advantages (mitigation of the beta-cell dysfunction, long lasting good metabolic control) and potential risks (hypoglycemia, weight gain, possible deteriorating patient complience) of early or timely insulin therapy. It is pointed out that the introduction of insulin is effective and safe therapeutic option during the whole course of type 2 diabetes, the use of different regimes is suitable to reach and maintain the individual glycemic target and, with a structured patient education, it does not disturb the quality of life and the compliance of patients. Orv. Hetil., 2014, 155(7), 255-261.",
keywords = "beta-cell dysfunction, body weight, early insulin treatment, hypoglycaemia, individual glycemic target",
author = "G. Winkler",
year = "2014",
month = "2",
day = "1",
doi = "10.1556/OH.2014.29828",
language = "Hungarian",
volume = "155",
pages = "255--261",
journal = "Orvosi Hetilap",
issn = "0030-6002",
publisher = "Akademiai Kiado",
number = "7",

}

TY - JOUR

T1 - Az inzulinkezelés korai megkezdése 2-es típusú cukorbetegségben

T2 - haszon és kockázat

AU - Winkler, G.

PY - 2014/2/1

Y1 - 2014/2/1

N2 - The introduction of insulin in type 2 diabetes is often too late, though the immediate as well as late consequences of inadequate metabolic control are well known. That is the reason, why a special attention is given in recent therapeutic guidelines for the importance of early, at least timely insulinisation. This review article summarizes the advantages (mitigation of the beta-cell dysfunction, long lasting good metabolic control) and potential risks (hypoglycemia, weight gain, possible deteriorating patient complience) of early or timely insulin therapy. It is pointed out that the introduction of insulin is effective and safe therapeutic option during the whole course of type 2 diabetes, the use of different regimes is suitable to reach and maintain the individual glycemic target and, with a structured patient education, it does not disturb the quality of life and the compliance of patients. Orv. Hetil., 2014, 155(7), 255-261.

AB - The introduction of insulin in type 2 diabetes is often too late, though the immediate as well as late consequences of inadequate metabolic control are well known. That is the reason, why a special attention is given in recent therapeutic guidelines for the importance of early, at least timely insulinisation. This review article summarizes the advantages (mitigation of the beta-cell dysfunction, long lasting good metabolic control) and potential risks (hypoglycemia, weight gain, possible deteriorating patient complience) of early or timely insulin therapy. It is pointed out that the introduction of insulin is effective and safe therapeutic option during the whole course of type 2 diabetes, the use of different regimes is suitable to reach and maintain the individual glycemic target and, with a structured patient education, it does not disturb the quality of life and the compliance of patients. Orv. Hetil., 2014, 155(7), 255-261.

KW - beta-cell dysfunction

KW - body weight

KW - early insulin treatment

KW - hypoglycaemia

KW - individual glycemic target

UR - http://www.scopus.com/inward/record.url?scp=84894220993&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84894220993&partnerID=8YFLogxK

U2 - 10.1556/OH.2014.29828

DO - 10.1556/OH.2014.29828

M3 - Article

VL - 155

SP - 255

EP - 261

JO - Orvosi Hetilap

JF - Orvosi Hetilap

SN - 0030-6002

IS - 7

ER -